GlycoMimetics (GLYC)
(Real Time Quote from BATS)
$0.17 USD
+0.01 (3.66%)
Updated Sep 19, 2024 11:26 AM ET
2-Buy of 5 2
F Value C Growth C Momentum F VGM
Income Statements
Fiscal Year end for GlycoMimetics, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 1 | 10 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 1 | 10 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 39 | 47 | 65 | 62 | 61 |
Income After Depreciation & Amortization | -39 | -47 | -63 | -52 | -61 |
Non-Operating Income | 2 | 1 | 0 | 0 | 4 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -37 | -47 | -63 | -51 | -58 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -37 | -47 | -63 | -51 | -58 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -37 | -47 | -63 | -51 | -58 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -39 | -47 | -63 | -51 | -61 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -39 | -47 | -63 | -52 | -61 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 63.34 | 52.53 | 51.45 | 45.72 | 43.26 |
Diluted EPS Before Non-Recurring Items | -0.58 | -0.89 | -1.23 | -1.12 | -1.34 |
Diluted Net EPS (GAAP) | -0.58 | -0.89 | -1.23 | -1.12 | -1.34 |
Fiscal Year end for GlycoMimetics, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 10.36 | 11.12 | 9.60 | 9.81 | 8.93 |
Income After SG&A, R&D, and Dept/Amort Expenses | -10.36 | -11.12 | -9.59 | -9.81 | -8.93 |
Non-Operating Income | 0.26 | 0.38 | 0.51 | 0.61 | 0.67 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -10.10 | -10.74 | -9.08 | -9.20 | -8.26 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -10.10 | -10.74 | -9.08 | -9.20 | -8.26 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -10.10 | -10.74 | -9.08 | -9.20 | -8.26 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 64.46 | 64.39 | 64.35 | 64.28 |
Diluted EPS Before Non-Recurring Items | NA | -0.17 | -0.14 | -0.14 | -0.13 |
Diluted Net EPS (GAAP) | -0.16 | -0.17 | -0.14 | -0.14 | -0.13 |